Mary Horowitz
玛丽·霍洛维茨
MD, MS
Chief Scientific Director, CIBMTR; Professor of MedicineCIBMTR首席科学主任;医学教授
👥Biography 个人简介
Mary Horowitz has led CIBMTR for decades, building the world's most comprehensive transplant outcomes registry and producing transformative epidemiological research that has defined standards, indications, and best practices for HSCT globally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
CIBMTR Outcomes Registry
Built and directed CIBMTR into the world's foremost transplant outcomes database, enabling landmark analyses of over 500,000 transplant recipients that have shaped international guidelines and clinical practice.
Donor Selection Science
Led pivotal studies comparing matched unrelated versus haploidentical donor outcomes, cord blood transplantation, and the impact of HLA matching, directly informing donor selection algorithms used worldwide.
Representative Works 代表性著作
Allogeneic bone marrow transplantation versus chemotherapy in multiple myeloma: a collaborative CIBMTR analysis
Journal of Clinical Oncology (2008)
Definitive registry comparison establishing the role and limitations of allo-BMT versus chemotherapy in myeloma.
Bone marrow versus peripheral blood as the stem cell source for sibling donor transplantation in adults with acute leukemia
Blood (2012)
BMTCTN randomized trial demonstrating differential GvHD and relapse outcomes by graft source, guiding clinical practice.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Brigham and Women's Hospital; Harvard Medical School
Kun-Hsing Yu
Harvard Medical School; Brigham and Women's Hospital
Ziad Obermeyer
University of California, Berkeley; UC San Francisco
Andrew H. Beck
PathAI; Harvard Medical School (formerly)
关注 玛丽·霍洛维茨 的研究动态
Follow Mary Horowitz's research updates
留下邮箱,当我们发布与 Mary Horowitz(Medical College of Wisconsin / CIBMTR)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment